Alto Ingredients
ALTO · NASDAQ
About ALTO
- Employees
- 390
- Headquarters
- Pekin, Illinois
- Listed
- Mar 24, 2005
- Sector
- Materials
- Industry
- Chemicals
- Website
- altoingredients.com
ALTO key statistics
- Market cap
- 276.14M
- Price-earnings ratio
- 5.13
- Dividend yield
- 0.46%
- Average volume
- 1.02M
- Volume
- 921.18K
- Open price
- $3.49
- High today
- $3.57
- Low today
- $3.47
- 52 Week high
- $6.11
- 52 Week low
- $0.9903
Alto Ingredients (ALTO) at a glance
As of Oct 20, 2026, Alto Ingredients (ALTO) shares are priced at $3.56, giving the company a market cap of 276.14M, a price-to-earnings ratio of 5.13 and a dividend yield of 0.46%.
Today the stock has traded between $3.47 and $3.57. The current price is 2.6% above the day's low and 0.3% below its high.
Volume so far is 921.18K shares, in line with the average of 1.02M shares a day.
Over the past year Alto Ingredients has ranged from $0.9903 to $6.11, and now sits 50% of the way up that range.
Alto Ingredients met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.15 per share against an estimate of $0.0867.
The average analyst price target is $8.50, 138.8% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $7.07
- Now
- $3.56
- High
- $10.50
ALTO earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 453.8% on average.
- Q3 FY24: reported -$0.04 per share against an estimate of $0.0357
- Q4 FY24: reported -$0.57 per share against an estimate of -$0.1173
- Q1 FY25: reported -$0.16 per share against an estimate of -$0.204
- Q2 FY25: reported -$0.15 per share against an estimate of -$0.1071
- Q3 FY25: reported $0.19 per share against an estimate of -$0.0561
- Q4 FY25: reported $0.28 per share against an estimate of -$0.0204
- Q1 FY26: reported $0.05 per share against an estimate of -$0.0306
- Q2 FY26: reported $0.15 per share against an estimate of $0.0867
ALTO news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
Alto Ingredients, Inc. to Release Second Quarter 2026 Financial Results on August 5, 2026
- Press releaseGlobe Newswire
Alto Ingredients, Inc. to Release First Quarter 2026 Financial Results on May 6, 2026
- Chris Katje
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
- Press releaseGlobe Newswire
Alto Ingredients, Inc. to Release Fourth Quarter and Year-end 2025 Financial Results on March 4, 2026
- Press releaseGlobe Newswire
Alto Ingredients, Inc. to Release Third Quarter 2025 Financial Results on November 5, 2025
- Press releaseGlobe Newswire
Alto Ingredients, Inc. to Release Second Quarter 2025 Financial Results on August 6, 2025
Insights into Alto Ingredients's Upcoming Earnings
Similar companies
Companies in the same industry as Alto Ingredients
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.